Robust estimation of protein expression ratios with lysate microarray technology

被引:35
作者
Mircean, C
Shmulevich, I [1 ]
Cogdell, D
Choi, WY
Jia, Y
Tabus, I
Hamilton, SR
Zhang, W
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Tampere Univ Technol, Inst Signal Proc, FIN-33101 Tampere, Finland
基金
芬兰科学院; 美国国家卫生研究院;
关键词
D O I
10.1093/bioinformatics/bti258
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: The protein lysate microarray is a developing proteomic technology for measuring protein expression levels in a large number of biological samples simultaneously. A challenge for accurate quantification is the relatively narrow dynamic range associated with the commonly used chromogenic signal detection system. To facilitate accurate measurement of the relative expression levels, each sample is serially diluted and each diluted version is spotted on a nitrocellulose-coated slide in triplicate. Thus, each sample yields multiple measurements in different dynamic ranges of the detection system. This study aims to develop suitable algorithms that yield accurate representations of the relative expression levels in different samples from multiple data points. Results: We evaluated two algorithms for estimating relative protein expression in different samples on the lysate microarray by means of a cross-validation procedure. For this purpose as well as for quality control we designed a 1440-spot lysate microarray containing 80 identical samples of purified bovine serum albumin, printed in triplicate with six 2-fold dilutions. Our analysis showed that the algorithm based on a robust least squares estimator provided the most accurate quantification of the protein lysate microarray data. We also demonstrated our methods by estimating relative expression levels of p53 and p21 in either p53(+/+) or p53(-/-) HCT116 colon cancer cells after two drug treatments and their combinations on another lysate microarray.
引用
收藏
页码:1935 / 1942
页数:8
相关论文
共 11 条
[1]  
Efron B., 1994, INTRO BOOTSTRAP, DOI DOI 10.1201/9780429246593
[2]   Protein microarrays: Molecular profiling technologies for clinical specimens [J].
Espina, V ;
Mehta, AI ;
Winters, ME ;
Calvert, V ;
Wulfkuhle, J ;
Petricoin, EF ;
Liotta, LA .
PROTEOMICS, 2003, 3 (11) :2091-2100
[3]   Signal pathway profiling of prostate cancer using reverse phase protein arrays [J].
Grubb, RL ;
Calvert, VS ;
Wulkuhle, JD ;
Paweletz, CP ;
Linehan, WM ;
Phillips, JL ;
Chuaqui, R ;
Valasco, A ;
Gillespie, J ;
Emmert-Buck, M ;
Liotta, LA ;
Petricoin, EF .
PROTEOMICS, 2003, 3 (11) :2142-2146
[4]  
Huber P. J., 1981, ROBUST STAT
[5]   Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells [J].
Ivanov, SS ;
Chung, AS ;
Yuan, ZL ;
Guan, YJ ;
Sachs, KV ;
Reichner, JS ;
Chin, YE .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (08) :788-795
[6]  
MacBeath G, 2000, SCIENCE, V289, P1760
[7]  
Neter John, 2004, APPL LINEAR REGRESSI
[8]   Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays [J].
Nishizuka, S ;
Charboneau, L ;
Young, L ;
Major, S ;
Reinhold, WC ;
Waltham, M ;
Kouros-Mehr, H ;
Bussey, KJ ;
Lee, JK ;
Espina, V ;
Munson, PJ ;
Petricoin, E ;
Liotta, LA ;
Weinstein, JN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14229-14234
[9]   Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front [J].
Paweletz, CP ;
Charboneau, L ;
Bichsel, VE ;
Simone, NL ;
Chen, T ;
Gillespie, JW ;
Emmert-Buck, MR ;
Roth, MJ ;
Petricoin, EF ;
Liotta, LA .
ONCOGENE, 2001, 20 (16) :1981-1989
[10]   A NOTE ON COMPUTING ROBUST REGRESSION ESTIMATES VIA ITERATIVELY REWEIGHTED LEAST-SQUARES [J].
STREET, JO ;
CARROLL, RJ ;
RUPPERT, D .
AMERICAN STATISTICIAN, 1988, 42 (02) :152-154